Case Introduction Highlights ctDNA as Emerging Risk Factor

The article presents a case introduction that focuses on circulating tumor DNA (ctDNA) as a potential emerging risk factor.

It outlines the relevance of ctDNA in assessing disease risk, emphasizing its growing importance in clinical considerations.

While details are limited, the piece underscores the need for further investigation into ctDNA's role in risk stratification.

Overall, the discussion points to ctDNA as a promising biomarker for future research and clinical application.